Contract Pharmaceuticals Limited Canada is recalling 57,625 bottles of Clindamycin Phosphate (clindamycin phosphate) Topical Solution USP, 1% (60 mL) due to slow leakage from the containers. The recall involves specific lots manufactured for Marlex Pharmaceuticals and Glasshouse Pharmaceuticals after stability testing showed the bottles were leaking and falling below the required weight specifications. If you have this medication, contact your healthcare provider or pharmacist regarding the recall and return any unused portions to your place of purchase or contact the manufacturer.
The containers may leak slowly over time, which results in the product falling below its specified weight. While this defect is considered low risk, it can lead to a loss of medication volume and potential leakage onto other items.
You have 2 options:
Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720
Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.